Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice

Laboratory Investigation

Volumn 96, Issue 1, 2016, Pages 25-36

  Nagasu, Hajime ^a   Satoh, Minoru ^a   Kiyokage, Emi ^a   Kidokoro, Kengo ^a   Toida, Kazunori ^a   Channon, Keith M ^b   Kanwar, Yashpal S ^c   Sasaki, Tamaki ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; GLUCOSE; LECTIN; MESSENGER RNA; N ACETYLGLUCOSAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; GLUCOSE BLOOD LEVEL; REACTIVE OXYGEN METABOLITE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE EXACERBATION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; GLYCOCALYX; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; ANALYSIS; ANIMAL; CHEMISTRY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MALE; MICE; NADPH OXIDASE; PODOCYTES; REACTIVE OXYGEN SPECIES;

EID: 84952016285     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.128     Document Type: Article

References (55)

1. Alebiosu CO, Ayodele OE. The global burden of chronic kidney disease and the way forward. Ethn Dis 2005; 15: 418-423
2. Krolewski AS, Warram JH, Rand LI, et al. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390-1398
3. Maeda S, Kobayashi MA, Araki S, et al. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 2010; 6: e1000842
4. Hamada Y, Miyata S, Nii-Kono T, et al. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol Dial Transplant 2007; 22: 1547-1557
5. Raj DS, Choudhury D, Welbourne TC, et al. Advanced glycation end products: a Nephrologist's perspective. Am J Kidney Dis 2000; 35: 365-380
6. Qian Y, Feldman E, Pennathur S, et al. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008; 57: 1439-1445
7. Avogaro A, Albiero M, Menegazzo L, et al. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011; 34: S285-S290
8. Hirano T, Ookubo K, Kashiwazaki K, et al. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease. Clin Chim Acta 2000; 299: 65-75
9. Schaffer SW, Jong CJ, Mozaffari M. Role of oxidative stress in diabetesmediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascul Pharmacol 2012; 57: 139-149
10. Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288: F1144-F1152
11. Kuwabara A, Satoh M, Tomita N, et al. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010; 53: 2056-2065
12. Bendall JK, Rinze R, Adlam D, et al. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-Targeted Nox2 transgenic mice. Circ Res 2007; 100: 1016-1025
13. Yoshioka M, Kayo T, Ikeda T, et al. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997; 46: 887-894
14. Nagasu H, Satoh M, Kuwabara A, et al. Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signals. Biochem Biophys Res Commun 2011; 407: 39-43
15. Rey FE, Cifuentes ME, Kiarash A, et al. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 2001; 89: 408-414
16. Nagasu H, Satoh M, Yorimitsu D, et al. Comparison of combination therapy of olmesartan plus azelnidipine or hydrochlorothiazide on renal and vascular damage in SHR/NDmcr-cp rats. Kidney Blood Press Res 2011; 34: 87-96
17. Takemoto M, Asker N, Gerhardt H, et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 2002; 161: 799-805
18. Koya D, Hayashi K, Kitada M, et al. Effects of antioxidants in diabetesinduced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003; 14: S250-S253
19. Nagasu H, Satoh M, Kuwabara A, et al. Renal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl saltsensitive rats. Nephrol Dial Transplant 2010; 25: 2889-2898
20. Satoh M, Kobayashi S, Kuwabara A, et al. In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocininduced diabetic rats. Microcirculation 2010; 17: 103-112
21. Ichimura K, Stan RV, Kurihara H, et al. Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol 2008; 19: 1463-1471
22. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88: 451-487
23. Patel K, Harding P, Haney LB, et al. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization. J Cell Physiol 2003; 195: 435-445
24. Stephenson LA, Haney LB, Hussaini IM, et al. Regulation of smooth muscle alpha-Actin expression and hypertrophy in cultured mesangial cells. Kidney Int 1998; 54: 1175-1187
25. Hoshi S, Shu Y, Yoshida F, et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 2002; 82: 25-35
26. Gorin Y, Block K, Hernandez J, et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 2005; 280: 39616-39626
27. Asaba K, Tojo A, Onozato ML, et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 2005; 67: 1890-1898
28. Liu GC, Fang F, Zhou J, et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 2012; 55: 2522-2532
29. Jha JC, Gray SP, Barit D, et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in longterm diabetic nephropathy. J Am Soc Nephrol 2014; 25: 1237-1254
30. Satoh M, Fujimoto S, Arakawa S, et al. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol Dial Transplant 2008; 23: 3806-3813
31. Kobayashi S, Satoh M, Namikoshi T, et al. Blockade of serotonin 2 A receptor improves glomerular endothelial function in rats with streptozotocininduced diabetic nephropathy. Clin Exp Nephrol 2008; 12: 119-125
32. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 2009; 82: 9-20
33. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 266-274
34. Popov D, Simionescu M. Cellular mechanisms and signalling pathways activated by high glucose and AGE-Albumin in the aortic endothelium. Arch Physiol Biochem 2006; 112: 265-273
35. Bodor C, Nagy JP, Vegh B, et al. Angiotensin II increases the permeability and PV-1 expression of endothelial cells. Am J Physiol Cell Physiol 2012; 302: C267-C276
36. Mallat Z, Hugel B, Ohan J, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353
37. Jansen F, Yang X, Franklin BS, et al. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovasc Res 2013; 98: 94-106
38. Salmon AH, Ferguson JK, Burford JL, et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J Am Soc Nephrol 2012; 23: 1339-1350
39. Fu J, Lee K, Chuang PY, et al. Glomerular endothelial cell injury and crosstalk in diabetic kidney disease. Am J Physiol Renal Physiol 2014; 308: F287-F297
40. Friden V, Oveland E, Tenstad O, et al. The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int 2011; 79: 1322-1330
41. Lu WC, Liu YN, Kang BB, et al. Trans-Activation of heparanase promoter by ETS transcription factors. Oncogene 2003; 22: 919-923
42. Singh AK, Gudehithlu KP, Pegoraro AA, et al. Vascular factors altered in glucose-Treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Lab Invest 2004; 84: 597-606
43. Kitahara T, Hiromura K, Ikeuchi H, et al. Mesangial cells stimulate differentiation of endothelial cells to form capillary-like networks in a three-dimensional culture system. Nephrol Dial Transplant 2005; 20: 42-49
44. Mao Y, Ootaka T, Saito T, et al. The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells. Clin Exp Nephrol 2003; 7: 201-209
45. Makino H, Kashihara N, Sugiyama H, et al. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes 1996; 45: 488-495
46. Graham S, Ding M, Sours-Brothers S, et al. Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes. Am J Physiol Renal Physiol 2007; 293: F1381-F1390
47. Weil EJ, Lemley KV, Mason CC, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 2012; 82: 1010-1017
48. Toyoda M, Najafian B, Kim Y, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007; 56: 2155-2160
49. Lindenmeyer MT, Kretzler M, Boucherot A, et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776
50. Siddiqi FS, Advani A. Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes. Diabetes 2013; 62: 3647-3655
51. Kanwar YS. Continuum of historical controversies regarding structural-functional relationship of the glomerular ultrafiltration unit (GUU). Am J Physiol Renal Physiol 2014; 308: F420-F424
52. Eremina V, Cui S, Gerber H, et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006; 17: 724-735
53. Sison K, Eremina V, Baelde H, et al. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol 2010; 21: 1691-1701
54. Yuen DA, Stead BE, Zhang Y, et al. eNOS deficiency predisposes podocytes to injury in diabetes. J Am Soc Nephrol 2012; 23: 1810-1823
55. Daehn I, Casalena G, Zhang T, et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest 2014; 124: 1608-1621